uniQure N.V. UQ1.F Stock
uniQure N.V. Price Chart
uniQure N.V. UQ1.F Financial and Trading Overview
| uniQure N.V. stock price | 4.47 EUR |
| Previous Close | 17.5 EUR |
| Open | 17.1 EUR |
| Bid | 17.16 EUR x 70000 |
| Ask | 17.64 EUR x 60000 |
| Day's Range | 17.1 - 17.1 EUR |
| 52 Week Range | 12.72 - 26.07 EUR |
| Volume | 3 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 813.69M EUR |
| Beta (5Y Monthly) | 1.155281 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -5.7 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 66.12 EUR |
UQ1.F Valuation Measures
| Enterprise Value | 704.11M EUR |
| Trailing P/E | N/A |
| Forward P/E | -12.954545 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 7.3960733 |
| Price/Book (mrq) | 1.9698192 |
| Enterprise Value/Revenue | 6.4 |
| Enterprise Value/EBITDA | -4.733 |
Trading Information
uniQure N.V. Stock Price History
| Beta (5Y Monthly) | 1.155281 |
| 52-Week Change | 44.96% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 26.07 EUR |
| 52 Week Low | 12.72 EUR |
| 50-Day Moving Average | 18.34 EUR |
| 200-Day Moving Average | 19.62 EUR |
UQ1.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 47.58M |
| Float | 41.58M |
| Short Ratio | N/A |
| % Held by Insiders | 8.00% |
| % Held by Institutions | 88.76% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -143.014% |
| Operating Margin (ttm) | -143.34% |
| Gross Margin | -93.90% |
| EBITDA Margin | -135.21% |
Management Effectiveness
| Return on Assets (ttm) | -14.19% |
| Return on Equity (ttm) | -32.82% |
Income Statement
| Revenue (ttm) | 110.02M EUR |
| Revenue Per Share (ttm) | 2.34 EUR |
| Quarterly Revenue Growth (yoy) | 197.19% |
| Gross Profit (ttm) | -87370000 EUR |
| EBITDA | -148756992 EUR |
| Net Income Avi to Common (ttm) | -157338000 EUR |
| Diluted EPS (ttm) | -3.16 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 315.34M EUR |
| Total Cash Per Share (mrq) | 6.63 EUR |
| Total Debt (mrq) | 142M EUR |
| Total Debt/Equity (mrq) | 34.4 EUR |
| Current Ratio (mrq) | 6.673 |
| Book Value Per Share (mrq) | 8.681 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -197651008 EUR |
| Levered Free Cash Flow (ttm) | -132422248 EUR |
Profile of uniQure N.V.
| Country | Germany |
| State | N/A |
| City | Amsterdam |
| Address | Paasheuvelweg 25 |
| ZIP | 1105 BP |
| Phone | 31 20 240 6000 |
| Website | https://www.uniqure.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 501 |
uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases. It offers HEMGENIX that has completed Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also develops AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease; AMT-162, which is in preclinical trial for the treatment of superoxide dismutase 1- amyotrophic lateral sclerosis; AMT-260 that is in preclinical trial to treat temporal lobe epilepsy; AMT-191, which is in preclinical trial for the treatment of fabry disease; AMT-161 that is in preclinical trial to treat amyotrophic lateral sclerosis caused by mutations; AMT-240, which is in preclinical trial to for the treatment of autosomal dominant Alzheimer's disease; and AMT-210 that is in preclinical trial to treat Parkinson's disease. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
Q&A For uniQure N.V. Stock
What is a current UQ1.F stock price?
uniQure N.V. UQ1.F stock price today per share is 4.47 EUR.
How to purchase uniQure N.V. stock?
You can buy UQ1.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for uniQure N.V.?
The stock symbol or ticker of uniQure N.V. is UQ1.F.
Which industry does the uniQure N.V. company belong to?
The uniQure N.V. industry is Biotechnology.
How many shares does uniQure N.V. have in circulation?
The max supply of uniQure N.V. shares is 50.05M.
What is uniQure N.V. Price to Earnings Ratio (PE Ratio)?
uniQure N.V. PE Ratio is now.
What was uniQure N.V. earnings per share over the trailing 12 months (TTM)?
uniQure N.V. EPS is -5.7 EUR over the trailing 12 months.
Which sector does the uniQure N.V. company belong to?
The uniQure N.V. sector is Healthcare.